| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.1M | +50.7% |
| Cost of Revenue | $4.7M | +29.2% |
| Gross Profit | $11.4M | +61.9% |
| R&D Expense | $20.6M | +21.4% |
| SG&A Expense | $32.1M | +38.5% |
| Operating Income | -$41.3M | -24.8% |
| Interest Expense | $394K | -34.3% |
| Pre-tax Income | -$42.3M | -52.1% |
| Income Tax | $252K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.7M | +8.8% |
| Accounts Receivable | $7.2M | +2.2% |
| Inventory | $8.2M | +42.0% |
| Current Assets | $76.1M | +10.2% |
| Total Assets | $77.5M | +10.3% |
| Current Liabilities | $6.1M | -7.5% |
| Long-term Debt | $4.5M | -3.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.2M | -62.9% |
| Capital Expenditures | $176K | — |
| Investing Cash Flow | -$242K | — |
| Financing Cash Flow | $41.1M | -24.8% |
| Free Cash Flow | -$38.4M | — |
| — |
| Net Income | -$42.6M | -53.0% |
| EPS (Basic) | $1.41 | +25.9% |
| EPS (Diluted) | $1.41 | +25.9% |
| Total Liabilities |
| $11.0M |
| +12.5% |
| Stockholders' Equity | $66.4M | +10.0% |